Angeion Corporation develops, manufactures, and distributes implantable cardioverter defibrillators (ICDs) and catheter ablation systems for the management of various types of arrhythmias, or abnormal heartbeats.

Our involvement: Strategic assistance with extraction from an adversarial corporate partner, strategy, identification of, and negotiation assistance with new strategic partner which bought $30 million investment, realignment of product development plan, acting CFO of this public company, lead $22 M PIPE. Assisted with recruiting new CEO.